Product
610
2 clinical trials
1 indication
Indication
AsthmaClinical trial
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of 610 in Chinese Adult Subjects With Severe Eosinophilic AsthmaStatus: Not yet recruiting, Estimated PCD: 2026-06-01
Clinical trial
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase Ib Study to Determine the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Recombinant Anti-IL-5 Humanized Monoclonal Antibody Therapy in Adult Subjects With Severe Eosinophilic AsthmaStatus: Active (not recruiting), Estimated PCD: 2023-09-01